Cerdulatinib for treating hematological cancers
US10736895B2 · kind B2 · utility
1Cited by
8References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2016 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Dec 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods and uses of cerdulatinib for treating diseases or conditions, including hematological cancers, and combinations of cerdulatinib for treating such diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.